In HF with secondary MR at high surgical risk, TEER was noninferior to surgery for CV events and reduced safety events at 1 y.

Transcatheter repair versus mitral-valve surgery for secondary mitral regurgitation. N Engl J Med. 2024;391:1787-1798.

In adults with AMI who are at risk for HF, empagliflozin did not reduce a composite of first HF hospitalization or all-cause death at 18 mo.

Butler J, Jones WS, Udell JA, et al. N Engl J Med. 2024;390:1455-1466.

In noncardiac thoracic surgery, low-dose colchicine did not reduce AF or myocardial injury after noncardiac surgery at 14 d.

Conen D, Ke Wang M, Popova E, et al; COP-AF Investigators. Lancet. 2023;402:1627-1635.

Reduced dietary sodium did not reduce clinical events in heart failure.

Ezekowitz JA, Colin-Ramirez E, Ross H, et al. Lancet. 2022;399:1391-400.